MicroRNA in prostate cancer

Kasomva Khanmi1, Savarimuthu Ignacimuthu2, Michael Gabriel Paulraj1

  • 1Molecular Biology Unit, Entomology Research Institute, Loyola College, Nungambakkam, Chennai 600 034, India.

Insights

This review examines microRNAs (miRNAs) and their role in prostate cancer development. It highlights how these small RNAs impact gene regulation and influence potential clinical therapies for male prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer (PCa) is a leading malignancy in US males, posing a significant mortality risk.
  • MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression in physiological and pathophysiological processes.

Purpose of the Study:

  • To review the regulation of miRNAs in prostate cancer.
  • To elucidate the mechanisms by which miRNAs contribute to prostate carcinogenesis.
  • To discuss the relationship between miRNAs and androgen signaling in PCa.
  • To explore the therapeutic potential of miRNAs in clinical settings.

Main Methods:

  • Literature review focusing on miRNA regulation in prostate cancer.
  • Analysis of miRNA mechanisms in prostate carcinogenesis.
  • Examination of miRNA interactions with androgen signaling pathways.

Main Results:

  • miRNAs play a crucial role in regulating gene expression relevant to prostate cancer.
  • Specific miRNA dysregulation contributes to the development and progression of prostate cancer.
  • Androgen signaling significantly influences miRNA expression patterns in prostate cancer.

Conclusions:

  • Understanding miRNA regulation is key to deciphering prostate carcinogenesis.
  • miRNAs hold promise as diagnostic biomarkers and therapeutic targets for prostate cancer.
  • Further research into miRNA-androgen signaling interactions could lead to novel treatment strategies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs01:22

MicroRNAs

12.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K